IBM announced it is offering the IBM Db2 Developer Extension for Visual Studio (VS) Code-now generally available. Developers live in VS Code, but Db2 development often means switching tools to set up ...

The data engineer started as a casual reader of the Jeffrey Epstein files. Then he became obsessed, and built the most ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Document database pipelines may be being affected by schema drift: a guide for developers and DBAs from 3T Software Labs' ...

Data center developers are finding opportunity just beyond St. Louis’ suburbs, where an abundance of land and availability of power are driving demand.

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial ...

Supabase, a popular developer database platform, has been blocked in India — one of its key markets — TechCrunch has learned. New Delhi ordered internet providers to block its website, resulting in ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Chinese RNA-based medicine developer Suzhou Ribo Life Science has filed a Hong Kong IPO, aiming to raise new funds for its lead RBD4059 drug candidate for thrombotic diseases. The small-interfering ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion its initial public offering in the United States. The Somerville, ...

Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...

American Soluna Holdings, Inc. has received a scalable loan product worth up to $100 million from sustainable infrastructure investor Generate Capital, PBC. This is stated in the company's message.